CRY - CryoLife, Inc.
| Previous Close | 26.32 |
| Open | 26.26 |
| Bid | 25.28 x 1100 |
| Ask | 26.95 x 800 |
| Day's Range | 25.89 - 26.62 |
| 52 Week Range | 20.76 - 33.00 |
| Volume | 183,098 |
| Avg. Volume | 185,242 |
| Market Cap | 1.024B |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | 569.57 |
| EPS (TTM) | 0.05 |
| Earnings Date | Apr 27, 2020 - May 03, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 08, 2015 |
| 1y Target Est | 34.83 |
- Thomson Reuters StreetEvents
Edited Transcript of CRY earnings conference call or presentation 13-Feb-20 9:30pm GMT
Q4 2019 CryoLife Inc Earnings Call
- Zacks
CryoLife (CRY) Tops Q4 Earnings Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 42.86% and -4.46%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results
Fourth Quarter and Recent Business Highlights:
- Zacks
CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on Thursday, February 13, 2020 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of CryoLife, Inc.
- Simply Wall St.
Should You Worry About CryoLife, Inc.'s (NYSE:CRY) CEO Salary Level?
In 2014 Pat MacKin was appointed CEO of CryoLife, Inc. (NYSE:CRY). This analysis aims first to contrast CEO...
- Zacks
Zacks.com featured highlights include: Carrols, Braskem, FirstService and CryoLife
Zacks.com featured highlights include: Carrols, Braskem, FirstService and CryoLife
- Zacks
5 Toxic Stocks to Disown or Play Short to Book Profits
Figuring out bloated toxic stocks on a regular basis and discarding them at the right time is the key to successful investing.
- PR Newswire
CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) pursuant to an Investigational New Drug (IND) application to begin the PROACT Xa clinical trial, a prospective, randomized, trial to determine if patients with an On-X mechanical aortic valve can be maintained safely and effectively on apixaban (Eliquis®) rather than warfarin.
- PR Newswire
CryoLife and Misonix Enter Into Distribution Agreement for NeoPatch
CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into an agreement whereby Misonix (NASDAQ: MSON) will have exclusive US commercialization rights for CryoLife's NeoPatch product to treat a broad range of indications outside of cardiac and vascular surgery.
- Simply Wall St.
If You Had Bought CryoLife (NYSE:CRY) Shares Five Years Ago You'd Have Made 151%
CryoLife, Inc. (NYSE:CRY) shareholders might be concerned after seeing the share price drop 14% in the last quarter...
- Insider Monkey
Is Cryolife Inc (CRY) Going To Burn These Hedge Funds ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
- PR Newswire
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections. The E-nya thoracic stent graft will be manufactured at the Company's facility in Hechingen, Germany.
- GlobeNewswire
Cryptologic Releases 2019 Third Quarter Financial Results
TORONTO, Nov. 27, 2019 -- Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the quarter ended September 30, 2019. Selected.
- Simply Wall St.
Are Investors Undervaluing CryoLife, Inc. (NYSE:CRY) By 21%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of CryoLife, Inc...
- Thomson Reuters StreetEvents
Edited Transcript of CRY earnings conference call or presentation 30-Oct-19 9:30pm GMT
Q3 2019 CryoLife Inc Earnings Call
- Zacks
CryoLife (CRY) Q3 Earnings Top Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
CryoLife Reports Third Quarter 2019 Financial Results
ATLANTA , Oct. 30, 2019 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase ...
- Insider Monkey
Hedge Funds Have Never Been More Bullish On Cryolife Inc (CRY)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
- Zacks
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial Results
ATLANTA , Oct. 16, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter financial results will ...
- Simply Wall St.
Why CryoLife, Inc.’s (NYSE:CRY) Return On Capital Employed Might Be A Concern
Today we'll evaluate CryoLife, Inc. (NYSE:CRY) to determine whether it could have potential as an investment idea. In...
- PR Newswire
CryoLife to Participate in the Deutsche Bank 27th Annual Leveraged Finance Conference
ATLANTA , Sept. 18, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat ...
- Simply Wall St.
These 4 Measures Indicate That CryoLife (NYSE:CRY) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
- Zacks
CryoLife Enters Agreement With Endospan for Aortic Stent
CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.
